logo-loader
Dyadic International Inc

Dyadic International makes strong start to 2019 with further deals and NASDAQ move

Dyadic International Inc's (OTCMKTS:DYAI) Ping Rawson speaks to Proactive's Andrew Scott while at the Spring Investor Summit 2019 in New York City.

The Jupiter, Florida-based biotechnology platform company, engages in the development, and large scale manufacture of low-cost enzymes and other proteins for diverse market opportunities in the United States and Europe.

Quick facts: Dyadic International Inc

Price: $6.20

Market: NASDAQ
Market Cap: $168.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Dyadic International Inc named herein, including the promotion by the Company of Dyadic International Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Dyadic International reveals newest research collaboration

Dyadic International Inc (NASDAQ:DYAI) CEO Mark Emalfarb tells Proactive the biotech saw continued momentum with a research collaboration deal signed with a 'top tier' pharma company.  Emalfarb, who also discussed the firm's second quarter earnings, says this pharma company is aligned...

6 days, 6 hours ago

2 min read